New Jersey, United States, February 2026 — Pooja Mankani has been promoted to Senior Director, AI Engineering and Enablement at Bristol Myers Squibb, marking a significant advancement in her leadership journey within the organization.
Pooja joined Bristol Myers Squibb in October 2023 as Director, AI Engineering and Enablement, where she played a pivotal role in advancing AI-driven engineering capabilities and strengthening enablement frameworks across the enterprise. Her promotion reflects her sustained impact in building scalable AI platforms and driving innovation within the biopharmaceutical ecosystem.
Prior to joining Bristol Myers Squibb, she served as Senior Manager at Capital One, where she led the development of a data platform designed to simplify data discovery, governance, and usability. She managed a team of full-stack engineers and contributed hands-on to platform development initiatives.
Earlier in her career, Pooja held engineering leadership roles at Syngenta and Motorola Solutions, where she managed global development teams, led architecture design for complex applications, and drove digital commerce and automation initiatives. She also gained extensive technical and leadership experience at Tieto, KPIT, and as a mobile application developer, building a strong foundation in enterprise software engineering and cloud technologies.
Pooja holds a Master of Science in Computer Science from Illinois Institute of Technology, further strengthening her technical expertise in data systems and AI-driven innovation.
Her elevation to Senior Director underscores Bristol Myers Squibb’s continued focus on leveraging AI and advanced analytics to accelerate scientific discovery and deliver transformational therapies to patients worldwide.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company dedicated to transforming patients’ lives through science. The company focuses on discovering, developing, and delivering innovative medicines in oncology, hematology, immunology, cardiovascular disease, and fibrosis. Through cutting-edge research, translational medicine, and data analytics, Bristol Myers Squibb strives to deliver the right medicine to the right patient at the right time.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
